{
  "ptid_time": "016_S_5251_2013-08-09",
  "img_path": "/data/qiuhui/data/adni/images/016_S_5251/2013-08-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,050 mm³, 48.0% above the reference mean. With a Z-score of 1.20 (88.5th percentile), this represents mild enlargement; hippocampal volume measures 5,697 mm³, 25.9% below the reference mean. With a Z-score of -2.90 (0.2th percentile), this represents significant atrophy; whole brain volume measures 874,118 mm³, 15.1% below the reference mean. With a Z-score of -1.88 (3.0th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 66.1 years. Gender is Female. Education: 16 years. MMSE: 26.0. MoCA: 19.0. Logical Memory: 1.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.51 SUVR (profound elevated); Amyloid beta: 787.10 pg/mL (normal ); Total tau: 708.00 pg/mL (profound elevated); Phosphorylated tau: 70.45 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant hippocampal atrophy (Z-score -2.90) and moderate whole-brain atrophy (Z-score -1.88), along with elevated biomarkers (T-tau, P-tau, AV45) despite normal Aβ, suggesting a tauopathy such as Alzheimer’s disease. The cognitive scores (MMSE 26, MoCA 19) indicate mild cognitive impairment, not yet severe enough for dementia.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s pathology)**  \n**Confidence:** **High**  \n\n*(Note: The discrepancy between MMSE (near-normal) and MoCA (impaired) suggests MoCA is more sensitive here. Biomarkers strongly support underlying AD pathology, but clinical symptoms align with MCI rather than full dementia.)*",
  "timestamp": "2025-07-26T00:39:01.801662"
}